Publication list
2022
Óvári, I.,
Szilágyi, V.,
Viczján, G.,
Lampé, N.,
Bege, M.,
Borbás, A.,
Herczeg, P.,
Juhász, B.,
Gesztelyi, R.,
Erdei, T.:
Egy újonnan szintetizált adenozin analóg, a hipoxantin-triciklánó hatása izolált patkány bal és jobb pitvaron.
Eü. Innov. Szle. 1 (1), 9-16, 2022.
Priksz, D.,
Lampé, N.,
Kovács, Á.,
Herwig, M.,
Bombicz, M.,
Varga, B.,
Wilisicz, T.,
Szilvássy, J.,
Pósa, A.,
Kiss, R.,
Gesztelyi, R.,
Ráduly, A.,
Szekeres, R.,
Sieme, M.,
Papp, Z.,
Tóth, A.,
Hamdani, N.,
Szilvássy, Z.,
Juhász, B.:
Nicotinic-acid derivative BGP-15 improves diastolic function in a rabbit model of atherosclerotic cardiomyopathy.
Br. J. Pharmacol. 179 (10), 2240-2258, 2022.
2021
Viczján, G.,
Erdei, T.,
Óvári, I.,
Lampé, N.,
Szekeres, R.,
Bombicz, M.,
Takács, B.,
Szilágyi, A.,
Zsuga, J.,
Szilvássy, Z.,
Juhász, B.,
Gesztelyi, R.:
A Body of Circumstantial Evidence for the Irreversible Ectonucleotidase Inhibitory Action of FSCPX, an Agent Known as a Selective Irreversible A1 Adenosine Receptor Antagonist So Far.
Int. J. Mol. Sci. 22 (18), 1-21, 2021.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
2020
Lampé, N.,
Priksz, D.,
Erdei, T.,
Bombicz, M.,
Kiss, R.,
Varga, B.,
Zsuga, J.,
Szerafin, T.,
Csanádi, Z.,
Balla, G.,
Balla, J.,
Szilvássy, Z.,
Gesztelyi, R.,
Juhász, B.:
Negative Inotropic Effect of BGP-15 on the Human Right Atrial Myocardium.
J. Clin. Med. 9 (5), 1-18, 2020.
2018
Szabó, K.,
Gesztelyi, R.,
Lampé, N.,
Kiss, R.,
Gálné Remenyik, J.,
Pesti-Asbóth, G.,
Priksz, D.,
Szilvássy, Z.,
Juhász, B.:
Fenugreek (Trigonella Foenum-Graecum) Seed Flour and Diosgenin Preserve Endothelium-Dependent Arterial Relaxation in a Rat Model of Early-Stage Metabolic Syndrome.
Int. J. Mol. Sci. 19 (3), 1-21, 2018.
Journal metrics:
Q1 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
Q1 Spectroscopy
Erdei, T.,
Szabó, A.,
Lampé, N.,
Szabó, K.,
Kiss, R.,
Zsuga, J.,
Papp, C.,
Pintér, Á.,
Szentmiklósi, J.,
Szilvássy, Z.,
Juhász, B.,
Gesztelyi, R.:
FSCPX, a chemical widely used as an irreversible A1 adenosine receptor antagonist, modifies the effect of NBTI, a nucleoside transport inhibitor, by reducing the interstitial adenosine level in the guinea pig atrium.
Molecules. 23 (9), 1-17, 2018.
Journal metrics:
Q2 Analytical Chemistry
Q1 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
2017
Zsuga, J.,
Erdei, T.,
Szabó, K.,
Lampé, N.,
Papp, C.,
Pintér, Á.,
Szentmiklósi, J.,
Juhász, B.,
Szilvássy, Z.,
Gesztelyi, R.:
Methodical Challenges and a Possible Resolution in the Assessment of Receptor Reserve for Adenosine, an Agonist with Short Half-Life.
Molecules. 22 (5), 1-17, 2017.
Journal metrics:
Q1 Analytical Chemistry
Q1 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
Varga, B.,
Priksz, D.,
Lampé, N.,
Bombicz, M.,
Kurucz, A.,
Szabó, A.,
Pósa, A.,
Szabó, R.,
Kemény-Beke, Á.,
Gálné Remenyik, J.,
Gesztelyi, R.,
Juhász, B.:
Protective Effect of Prunus Cerasus (Sour Cherry) Seed Extract on the Recovery of Ischemia/Reperfusion-Induced Retinal Damage in Zucker Diabetic Fatty Rat.
Molecules. 22 (10), [1-12], 2017.
Journal metrics:
Q1 Analytical Chemistry
Q1 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
updated: 2024-04-14, 01:55
